Cargando…

Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury

BACKGROUND: It is widely acknowledged that cisplatin-induced nephrotoxicity hinders its efficacy during clinical therapy. Effective pharmaceutical interventions for cisplatin-induced acute kidney injury (Cis-AKI) are currently lacking. Prior studies have implicated the chemokine CX3CL1 in the develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Qiming, Lai, Tengfang, Liang, Liudan, Jiang, Yan, Liu, Fahui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594885/ https://www.ncbi.nlm.nih.gov/pubmed/37875838 http://dx.doi.org/10.1186/s10020-023-00733-3

Ejemplares similares

CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma
por: Gong, Qiming, et al.
Publicado: (2022)

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
por: Ren, Jiafa, et al.
Publicado: (2021)

Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis
por: Zhou, Lu, et al.
Publicado: (2022)

The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice
por: Yu, Yong-Wu, et al.
Publicado: (2018)

Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis
por: He, Leyu, et al.
Publicado: (2023)

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
por: von Vietinghoff, Sibylle, et al.
Publicado: (2021)

NPAS2 ameliorates myocardial ischaemia/reperfusion injury in rats via CX3CL1 pathways and regulating autophagy
por: Huang, Jing, et al.
Publicado: (2021)

Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease
por: Zhang, Xiaoyi, et al.
Publicado: (2023)

Podocytes and microRNA-30/Cx43 axis in diabetic nephropathy
por: Kim, Seo Rin, et al.
Publicado: (2021)

Myo-Inositol Supplementation Alleviates Cisplatin-Induced Acute Kidney Injury via Inhibition of Ferroptosis
por: Qi, Huiyue, et al.
Publicado: (2022)

Sodium hydrogen sulfide (NaHS) ameliorates alterations caused by cisplatin in filtration slit diaphragm and podocyte cytoskeletal in rat kidney
por: Karimi, Asiyeh, et al.
Publicado: (2017)

Paclitaxel Ameliorates Palmitate-Induced Injury in Mouse Podocytes
por: Son, Seung Seob, et al.
Publicado: (2020)

Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis
por: Song, Jiayu, et al.
Publicado: (2022)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
por: Cormican, Sarah, et al.
Publicado: (2021)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Cytoskeletal confinement of CX(3)CL1 limits its susceptibility to proteolytic cleavage by ADAM10
por: Wong, Harikesh S., et al.
Publicado: (2014)

Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
por: Zhang, Huili, et al.
Publicado: (2012)

Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
por: Winter, Aimee N., et al.
Publicado: (2020)

MicroRNA-30/Cx43 axis contributes to podocyte injury by regulating ER stress in diabetic nephropathy
por: Li, Min, et al.
Publicado: (2020)

Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin
por: Alquraishi, Mohammed, et al.
Publicado: (2022)

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
por: Chen, Peiqing, et al.
Publicado: (2016)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Electroacupuncture Ameliorates Cerebral Ischemic Injury by Inhibiting Ferroptosis
por: Li, Guangda, et al.
Publicado: (2021)

Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
por: Imai, Toshio, et al.
Publicado: (2016)

Cochlear resident macrophage mediates development of ribbon synapses via CX3CR1/CX3CL1 axis
por: Song, Xinyu, et al.
Publicado: (2022)

CX3CL1 intracellular domain and adult neurogenesis
por: Benoit, Marc R., et al.
Publicado: (2019)

WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury
por: Deng, Zebin, et al.
Publicado: (2023)

Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice
por: DING, XIN-MIN, et al.
Publicado: (2016)

Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015)

SIRT1 Mediates Effects of FGF21 to Ameliorate Cisplatin-Induced Acute Kidney Injury
por: Chen, Qiongzhen, et al.
Publicado: (2020)

Isorhynchophylline Ameliorates Cerebral Ischemia/Reperfusion Injury by Inhibiting CX3CR1-Mediated Microglial Activation and Neuroinflammation
por: Deng, Yuanyuan, et al.
Publicado: (2021)

VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury
por: Li, Yan, et al.
Publicado: (2023)

SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease
por: Yang, Qianqian, et al.
Publicado: (2022)

Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury
por: He, Xu, et al.
Publicado: (2022)

Microvesicles derived from human Wharton’s Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1
por: Zou, Xiangyu, et al.
Publicado: (2014)

Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury
por: Sang, Yizhen, et al.
Publicado: (2020)

PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease
por: Zhang, Zongwei, et al.
Publicado: (2022)

C/EBPα deficiency in podocytes aggravates podocyte senescence and kidney injury in aging mice
por: Zhang, Liwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ovukbclk4kqeg1eqm0febtrug